Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.
Authors: Mayet A; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Parma B; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Lécuyer D; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland., Defruit A; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Rana S; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Bodac A; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015, Lausanne, Switzerland., Demetter P; Cerba Path, Division CMP, 1070, Bruxelles, Belgium., Denanglaire S; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium., Ireland AS; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27708, USA., Brandão M; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.; Thoracic Oncology Functional Unit, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Berghmans T; Thoracic Oncology Functional Unit, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium., Andris F; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium., Goriely S; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium., Perentes JY; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland., Oliver TG; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27708, USA., Meylan E; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium. Meylan.Etienne@chuv.ch.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium. Meylan.Etienne@chuv.ch.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium. Meylan.Etienne@chuv.ch.; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland. Meylan.Etienne@chuv.ch.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland. Meylan.Etienne@chuv.ch.
Source: EMBO molecular medicine [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1625-1647. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41917327
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mayet+A%22">Mayet A</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Parma+B%22">Parma B</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Lécuyer+D%22">Lécuyer D</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Defruit+A%22">Defruit A</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Rana+S%22">Rana S</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Bodac+A%22">Bodac A</searchLink>; Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, 1015, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Demetter+P%22">Demetter P</searchLink>; Cerba Path, Division CMP, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Denanglaire+S%22">Denanglaire S</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Ireland+AS%22">Ireland AS</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27708, USA.<br /><searchLink fieldCode="AU" term="%22Brandão+M%22">Brandão M</searchLink>; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.; Thoracic Oncology Functional Unit, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Berghmans+T%22">Berghmans T</searchLink>; Thoracic Oncology Functional Unit, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Andris+F%22">Andris F</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Goriely+S%22">Goriely S</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium.<br /><searchLink fieldCode="AU" term="%22Perentes+JY%22">Perentes JY</searchLink>; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Oliver+TG%22">Oliver TG</searchLink>; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27708, USA.<br /><searchLink fieldCode="AU" term="%22Meylan+E%22">Meylan E</searchLink>; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, 6041, Gosselies, Belgium. Meylan.Etienne@chuv.ch.; ULB Center for Research in Immunology (U-CRI), 6041, Gosselies, Belgium. Meylan.Etienne@chuv.ch.; Lung Cancer and Immuno-Oncology Laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université Libre de Bruxelles, 1070, Bruxelles, Belgium. Meylan.Etienne@chuv.ch.; Division of Thoracic Surgery, Department of Surgery, Lausanne University Hospital and University of Lausanne, 1011, Lausanne, Switzerland. Meylan.Etienne@chuv.ch.; Agora Cancer Research Center, and Swiss Cancer Center Léman, Lausanne, Switzerland. Meylan.Etienne@chuv.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2026 May; Vol. 18 (5), pp. 1625-1647. <i>Date of Electronic Publication: </i>2026 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41917327
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44321-026-00401-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1625
    Titles:
      – TitleFull: Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mayet A
      – PersonEntity:
          Name:
            NameFull: Parma B
      – PersonEntity:
          Name:
            NameFull: Lécuyer D
      – PersonEntity:
          Name:
            NameFull: Defruit A
      – PersonEntity:
          Name:
            NameFull: Rana S
      – PersonEntity:
          Name:
            NameFull: Bodac A
      – PersonEntity:
          Name:
            NameFull: Demetter P
      – PersonEntity:
          Name:
            NameFull: Denanglaire S
      – PersonEntity:
          Name:
            NameFull: Ireland AS
      – PersonEntity:
          Name:
            NameFull: Brandão M
      – PersonEntity:
          Name:
            NameFull: Berghmans T
      – PersonEntity:
          Name:
            NameFull: Andris F
      – PersonEntity:
          Name:
            NameFull: Goriely S
      – PersonEntity:
          Name:
            NameFull: Perentes JY
      – PersonEntity:
          Name:
            NameFull: Oliver TG
      – PersonEntity:
          Name:
            NameFull: Meylan E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1757-4684
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: EMBO molecular medicine
              Type: main
ResultId 1